TrialBlood advances2025
Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.
Inga M Schimansky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
TrialBlood advances2025
Inga M Schimansky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.